October 31, 2022
Via: The Wall Street JournalRival drugmakers are seeking to upend Pfizer Inc.’s dominance of the $7 billion worldwide market for pneumonia vaccines, launching what is shaping up to be one of the industry’s fiercest battles. Merck & Co. has already introduced a new competitor […]
Industry Focus Areas, Medical, Regulations
October 20, 2022
Via: The Wall Street JournalDrugmakers are trying to blunt Medicare’s newfound power to negotiate medicine prices while coping with internal industry disputes and ebbing influence in Washington, D.C. Under the Inflation Reduction Act, Congress gave Medicare, the country’s biggest buyer of prescription drugs, the […]
April 11, 2022
Via: The Wall Street JournalVaccine makers Pfizer Inc. and Moderna Inc. named company outsiders as chief financial officers as they look to deploy some of the cash they have generated during the Covid-19 pandemic. New York-based Pfizer on Monday said David Denton will take […]
July 9, 2024
June 25, 2024
Copyright © 2024. All rights reserved
